Sledge GW, Toi M, Neven P, et al. MONARCH 2: Abemaciclib in combination with fulvestrant in patients with HR+/HER2- advanced breast cancer who progressed on endocrine therapy. J Clin Oncol. 2017;35 (suppl; abstr 1000).
Poly (ADP-ribose) polymerase (PARP-)remmers bij het ovariumcarcinoom
sep 2018 | Gynaecologische oncologie